Zhang X, Guo T, Zhang Y, Jiao M, Ji L, Dong Z, et al. Global burden of Alzheimer’s disease and other dementias attributed to metabolic risks from 1990 to 2021: results from the Global Burden of Disease Study 2021. BMC Psychiatry. 2024;24:910.

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization. Dementia. 2021. https://www.who.int/news-room/fact-sheets/detail/dementia

Reitz C, Rogaeva E, Beecham GW. Late-onset vs nonmendelian early-onset Alzheimer disease: a distinction without a difference? Neurol Genet. 2020;6:e512.

Article  PubMed  PubMed Central  Google Scholar 

Sun M, Chen WM, Wu SY, Zhang J. Dementia risk after major elective surgery based on the route of anaesthesia: a propensity score-matched population-based cohort study. EClinicalMedicine. 2023;55:101727.

Article  PubMed  Google Scholar 

Hu J, Wang X. Alzheimer’s disease: from pathogenesis to mesenchymal stem cell therapy–bridging the missing link. Front Cell Neurosci. 2022;15:811852.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Agatonovic-Kustrin S, Kettle C, Morton DW. A molecular approach in drug development for Alzheimer’s disease. Biomed Pharmacother. 2018;106:553–65.

Article  CAS  PubMed  Google Scholar 

Dubois B, Villain N, Frisoni GB, Rabinovici GD, Sabbagh M, Cappa S, et al. Clinical diagnosis of Alzheimer’s disease: recommendations of the International Working Group. Lancet Neurol. 2021;20:484–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K. Alzheimer’s disease drug development pipeline: 2019. Alzheimer’s Dementia: Transl Res Clin Interv. 2019;5:272–93.

Article  Google Scholar 

Kabir MT, Uddin MS, Mamun AA, Jeandet P, Aleya L, Mansouri RA, et al. Combination drug therapy for the management of Alzheimer’s disease. Int J Mol Sci. 2020;21:3272.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karvelas N, Bennett S, Politis G, Kouris NI, Kole C. Advances in stem cell therapy in Alzheimer’s disease: a comprehensive trial review. Stem Cell Investig. 2022;9:2.

Duan Y, Lyu L, Zhan S. Stem cell therapy for Alzheimer’s disease: a scoping review for 2017–2022. Biomedicines. 2023;11:120.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shah AJ, Dar MY, Jan B, Qadir I, Mir RH, Uppal J, et al. Neural stem cell therapy for Alzheimer’s disease: a-state-of-the-art review. J Dement Alzheimer’s Dis. 2024;1:19–25.

Article  Google Scholar 

Boese AC, Hamblin MH, Lee JP. Neural stem cell therapy for neurovascular injury in Alzheimer’s disease. Exp Neurol. 2020;324:113112.

Article  CAS  PubMed  Google Scholar 

Huang D, Cao Y, Yang X, Liu Y, Zhang Y, Li C, et al. A nanoformulation‐mediated multifunctional stem cell therapy with improved beta‐amyloid clearance and neural regeneration for Alzheimer’s disease. Adv Mater. 2021;33:2006357.

Article  CAS  Google Scholar 

Liu Y, Huber CC, Wang H. Disrupted blood-brain barrier in 5xFAD mouse model of Alzheimer’s disease can be mimicked and repaired in vitro with neural stem cell-derived exosomes. Biochem Biophys Res Commun. 2020;525:192–6.

Article  CAS  Google Scholar 

Zhu Q, Zhang N, Hu N, Jiang R, Lu H, Xuan A, et al. Neural stem cell transplantation improves learning and memory by protecting cholinergic neurons and restoring synaptic impairment in an amyloid precursor protein/presenilin 1 transgenic mouse model of Alzheimer’s disease. Mol Med Rep. 2020;21:1172–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Armijo E, Edwards G, Flores A, Vera J, Shahnawaz M, Moda F, et al. Induced pluripotent stem cell-derived neural precursors improve memory, synaptic and pathological abnormalities in a mouse model of Alzheimer’s disease. Cells. 2021;10:1802.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao J, Su M, Lin Y, Liu H, He Z, Lai L. Administration of amyloid precursor protein gene deleted mouse ESC-derived thymic epithelial progenitors attenuates Alzheimer’s pathology. Front Immunol. 2020;11:1781.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song Y, Lim JY, Lim T, Im KI, Kim NYS, et al. Human mesenchymal stem cells derived from umbilical cord and bone marrow exert immunomodulatory effects in different mechanisms. World J Stem Cells. 2020;12:1032–49.

Article  PubMed  PubMed Central  Google Scholar 

Zhang X, Kuang Q, Xu J, Lin Q, Chi H, Yu D. MSC-based cell therapy in neurological diseases: a concise review of the literature in pre-clinical and clinical research. Biomolecules. 2024;14:538.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Uwishema O, Ghezzawi M, Wojtara M, Esene IN, Obamiro K. Stem cell therapy use in patients with dementia: a systematic review. Int J Emerg Med. 2025;18:95.

Article  PubMed  PubMed Central  Google Scholar 

Park BN, Kim JH, Lim TS, Park SH, Kim TG, Yoon BS, et al. Therapeutic effect of mesenchymal stem cells in an animal model of Alzheimer’s disease evaluated by β-amyloid positron emission tomography imaging. Aust N Z J Psychiatry. 2020;54:883–91.

Article  PubMed  Google Scholar 

Kou M, Huang L, Yang J, Chiang Z, Chen S, Liu J, et al. Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool? Cell Death Dis. 2022;13:580.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo M, Yin Z, Chen F, Lei P. Mesenchymal stem cell-derived exosome: a promising alternative in the therapy of Alzheimer’s disease. Alzheimers Res Ther. 2020;12:109.

Article  PubMed  PubMed Central  Google Scholar 

Santamaria G, Brandi E, Vitola P, Grandi F, Ferrara G, Pischiutta F, et al. Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice. Cell Death Differ. 2021;28:203–18.

Article  CAS  PubMed  Google Scholar 

Yan Y, Ma T, Gong K, Ao Q, Zhang X, Gong Y. Adipose-derived mesenchymal stem cell transplantation promotes adult neurogenesis in the brains of Alzheimer’s disease mice. Neural Regen Res. 2014;9:798–805.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qin C, Li Y, Wang K. Functional mechanism of bone marrow-derived mesenchymal stem cells in the treatment of animal models with Alzheimer’s disease: inhibition of neuroinflammation. J Inflamm Res. 2021;14:4761–75.

Article  PubMed  PubMed Central  Google Scholar 

Wei Y, Xie Z, Bi J, Zhu Z. Anti-inflammatory effects of bone marrow mesenchymal stem cells on mice with Alzheimer’s disease. Exp Ther Med. 2018;16:5015–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao Y, Chen X, Wu Y, Wang Y, Li Y, Xiang C. Transplantation of human menstrual blood-derived mesenchymal stem cells alleviates Alzheimer’s disease-like pathology in APP/PS1 transgenic mice. Front Mol Neurosci. 2018;11:140.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma T, Gong K, Ao Q, Yan Y, Song B, Huang H, et al. Intracerebral transplantation of adipose-derived mesenchymal stem cells alternatively activates microglia and ameliorates neuropathological deficits in Alzheimer’s disease mice. Cell Transplant. 2013:S113–26.

Article  PubMed  Google Scholar 

Xie ZH, Liu Z, Zhang XR, Yang H, Wei LF, Wang Y, et al. Wharton’s jelly-derived mesenchymal stem cells alleviate memory deficits and reduce amyloid-beta deposition in an APP/PS1 transgenic mouse model. Clin Exp Med. 2016;16:89–98.

Article  CAS  PubMed  Google Scholar 

Ghasemi